Emily Eugster
Overview
Explore the profile of Emily Eugster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winbo A, Ramanan S, Eugster E, Rydberg A, Jovinge S, Skinner J, et al.
Am J Physiol Heart Circ Physiol
. 2021 Jun;
321(1):H217-H227.
PMID: 34142889
Sympathetic activation is an established trigger of life-threatening cardiac events in long QT syndrome type 1 (LQT1). loss-of-function variants, which underlie LQT1, have been associated with both cardiac arrhythmia and...
2.
Winbo A, Ramanan S, Eugster E, Jovinge S, Skinner J, Montgomery J
Am J Physiol Heart Circ Physiol
. 2020 Aug;
319(5):H927-H937.
PMID: 32822546
Sympathetic neurons (SNs) capable of modulating the heart rate of murine cardiomyocytes (CMs) can be differentiated from human stem cells. The electrophysiological properties of human stem cell-derived SNs remain largely...
3.
Tarnawski L, Eugster E, DeCamp L, Jovinge S
Cell Reprogram
. 2019 Apr;
21(2):78-88.
PMID: 30969880
Induced pluripotent stem cells (iPSCs) remain a promising approach to target diseases with a loss of functional parenchyma. This technology comes with a number of concerns for clinical applications, including...
4.
Monsma D, Cherba D, Richardson P, Vance S, Rangarajan S, Dylewski D, et al.
Pediatr Blood Cancer
. 2014 Apr;
61(9):1570-7.
PMID: 24687871
Background: Precision (Personalized) medicine has the potential to revolutionize patient health care especially for many cancers where the fundamental disease etiology remains either elusive or has no available therapy. Here...
5.
Monks N, Cherba D, Kamerling S, Simpson H, Rusk A, Carter D, et al.
J Transl Med
. 2013 Jul;
11:158.
PMID: 23815880
Background: A successful therapeutic strategy, specifically tailored to the molecular constitution of an individual and their disease, is an ambitious objective of modern medicine. In this report, we highlight a...
6.
Mooney M, Bond J, Monks N, Eugster E, Cherba D, Berlinski P, et al.
PLoS One
. 2013 Apr;
8(4):e61088.
PMID: 23593398
Comparative oncology is a developing research discipline that is being used to assist our understanding of human neoplastic diseases. Companion canines are a preferred animal oncology model due to spontaneous...
7.
Monsma D, Monks N, Cherba D, Dylewski D, Eugster E, Jahn H, et al.
J Transl Med
. 2012 Jun;
10:125.
PMID: 22709571
Background: There is resurgence within drug and biomarker development communities for the use of primary tumorgraft models as improved predictors of patient tumor response to novel therapeutic strategies. Despite perceived...
8.
Maupin K, Sinha A, Eugster E, Miller J, Ross J, Paulino V, et al.
PLoS One
. 2010 Oct;
5(9):e13002.
PMID: 20885998
Background: The ability to selectively detect and target cancer cells that have undergone an epithelial-mesenchymal transition (EMT) may lead to improved methods to treat cancers such as pancreatic cancer. The...
9.
Song K, Gronemeyer B, Lu W, Eugster E, Tomkiel J
Exp Cell Res
. 2002 Apr;
275(1):81-91.
PMID: 11925107
Human centromere protein C (CENP-C) is an essential component of the inner kinetochore plate. A central region of CENP-C can bind DNA in vitro and is sufficient for targeting the...